Non-small-cell lung cancer
Showing 1 - 25 of >10,000
Identify Resected Non-small-cell Lung Cancer With High Risk of
Recruiting
- Non-small Cell Lung Cancer Stage IIIA
- Resected non small cell lung cancer
-
Toulouse, FranceJulien MAZIERES
Feb 8, 2023
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Not yet recruiting
- Lung Cancer, Non-small Cell
- Small Cell Lung Cancer
- (no location specified)
Nov 16, 2022
Blood Samples in Patients With Non-small Cell Lung Cancer
Recruiting
- Stage III Non-Small Cell Lung Cancer AJCC v7
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 18, 2022
Patients With Advanced Non-Small Cell Lung Cancer
Completed
- Non Small Cell Lung Cancer
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Jul 19, 2022
d To Treat People With Non-Small Cell Lung Cancer
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
-
Tokyo, JapanTakeda Selected Site
Oct 13, 2022
Examination of Trends in Non-Small Cell Lung Cancer Patients'
Not yet recruiting
- Non-Small Cell Lung Cancer
- (no location specified)
Mar 10, 2023
NSCLC Trial in Liège (induced sputum, lung biopsy, bronchoalveolar lavage)
Recruiting
- Non-small Cell Lung Cancer
- induced sputum
- +3 more
-
Liège, BelgiumCHU de Liège
Nov 7, 2022
Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body
Completed
- Recurrent Non-small Cell Lung Cancer
- +3 more
- therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
- quality-of-life assessment
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
NSCLC Trial
Not yet recruiting
- Non-small Cell Lung Cancer
- (no location specified)
Sep 14, 2022
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)
Not yet recruiting
- Non-Small Cell Lung Cancer(NSCLC)
- WX-0593 Tablets
-
Jinan, Shandong, ChinaShandong Cancer Hospital and Institute
Mar 1, 2023
Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)
Not yet recruiting
- Metastatic Non Small Cell Lung Cancer
- C-TIL051
-
Raleigh, North CarolinaDuke Cancer Institute
Jan 6, 2023
Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- (no location specified)
Jan 12, 2023
NSCLC Trial in Shanghai (Carbon ion beam radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Carbon ion beam radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Nov 10, 2022
NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- Garmin Vivofit Activity Tracker
- (no location specified)
Aug 31, 2022
Non Small Cell Lung Cancer, Stage IV NSCLC, Brain Metastases Trial in Hangzhou (Hypofractionated Stereotactic Radiotherap)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Hypofractionated Stereotactic Radiotherap
-
Hangzhou, ChinaKaicheng Pan
Oct 18, 2022
NSCLC, Metastatic NSCLC Trial (Tislelizumab, BGB-A445, LBL-007)
Not yet recruiting
- Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Tislelizumab
- +7 more
- (no location specified)
Dec 14, 2022
NSCLC Trial in Beijing (Pyrotinib)
Recruiting
- Non-small Cell Lung Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College
Feb 20, 2023
Whole Blood From Active Non-Small Cell Lung Cancer Supplemental
Recruiting
- Non Small Cell Lung Cancer
- Specimen sample
-
Waltham, MassachusettsSanguine Biosciences
Dec 28, 2022
NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
Cancer Medicines in Metastatic Non-small Cell Lung Cancer in
Not yet recruiting
- Non-Small Cell Lung Cancer
- lorlatinib
- +17 more
-
Oslo, NorwayPfizer Norway
Apr 17, 2023
NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)
Active, not recruiting
- Non-small Cell Lung Cancer
- Dendritic cell immunotherapy
- +2 more
-
Ghent, BelgiumGhent University Hospital
Dec 23, 2022
Genetic and Epigenetic Factors on Clinical Response and Toxicity
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Cisplatin injection
-
Cairo, EgyptAin Shams University
Feb 16, 2023